cytarabine 1000mg injection - Cytarabine (1000mg) medicine

Arasid 1000mg Injection (Cytarabine): Comprehensive Medicine Guide

No reviews yet
🏭 Pfizer Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Sep 25, 2026
⚠️ Hepatotoxicity Risk ⚠️ Nephrotoxicity Risk 📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for indicated uses.
Reviewed by
SaathiMed Expert Panel | Sep 25, 2026

When to Call Your Doctor IMMEDIATELY

  • Fever of 100.4°F (38°C) or higher, chills, or sore throat
  • Unusual bruising, bleeding gums, blood in urine or stool
  • Severe shortness of breath, chest pain, or palpitations
  • Confusion, seizures, severe headache, or vision changes
  • Severe mouth sores preventing eating or drinking
  • Yellowing of skin or eyes, dark urine, or severe abdominal pain
  • Decreased urine output or swelling in legs or feet
  • Severe skin rash with blistering or peeling

If experiencing severe symptoms, call emergency services immediately.

What is cytarabine 1000mg injection used for?

This medicine is a chemotherapy injection containing cytarabine 1000 mg, used mainly for acute myeloid leukemia and other blood cancers. It is given intravenously by a healthcare professional and works by blocking DNA synthesis in cancer cells. It can cause low blood counts, infections, and other side effects, so close monitoring is required.

  • Generic Name: Cytarabine
  • Manufacturer: Pfizer Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 cytarabine 1000mg injection के बारे में (Hindi Summary)

उपयोग: यह दवा मुख्य रूप से तीव्र माइलॉयड ल्यूकेमिया (AML), तीव्र लिम्फोब्लास्टिक ल्यूकेमिया (ALL), और मेनिन्जियल ल्यूकेमिया जैसे रक्त कैंसर के इलाज में उपयोग की जाती है। यह एक कीमोथेरेपी इंजेक्शन है जिसे सिर्फ अस्पताल या कैंसर विशेषज्ञ की देखरेख में नस के माध्यम से दिया जाता है। यह कैंसर कोशिकाओं के डीएनए को नष्ट करके उनकी वृद्धि को रोकती है। इसका उपयोग स्टेम सेल ट्रांसप्लांट से पहले भी किया जा सकता है।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में मतली, उल्टी, भूख न लगना, मुँह के छाले, दस्त, बुखार, थकान और त्वचा पर दाने शामिल हैं। यह रक्त कोशिकाओं को कम कर सकती है, जिससे संक्रमण, खून बहने और एनीमिया का खतरा बढ़ जाता है। कुछ रोगियों में फ्लू जैसे लक्षण, मांसपेशियों में दर्द, और सीने में परेशानी हो सकती है। गंभीर दुष्प्रभावों में गंभीर संक्रमण, लीवर और किडनी की समस्या, और दुर्लभ रूप से हृदय या तंत्रिका तंत्र की समस्याएं शामिल हैं। कोई भी नया बुखार, असामान्य खून बहना, सांस लेने में कठिनाई, या भ्रम होने पर तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल योग्य डॉक्टर या स्वास्थ्यकर्मी द्वारा अस्पताल में ही दी जानी चाहिए। इसे घर पर स्वयं न लगाएं। अपने डॉक्टर को अपनी सभी दवाओं, सप्लीमेंट्स और हर्बल उत्पादों के बारे में बताएं। संक्रमण से बचने के लिए हाथ धोते रहें और भीड़-भाड़ वाली जगहों से बचें। जब प्लेटलेट्स कम हों, तो नरम टूथब्रश और इलेक्ट्रिक रेजर का उपयोग करें। पर्याप्त पानी पिएं। डॉक्टर के बताए अनुसार दवाएं और आई ड्रॉप्स लें। इलाज के दौरान लाइव वैक्सीन न लगवाएं। गर्भधारण से बचने के लिए प्रभावी गर्भनिरोधक उपाय अपनाएं। 100.4°F (38°C) या अधिक बुखार, ठंड लगना, गले में खराश, आसानी से चोट लगना, पेशाब या मल में खून, तेज सिरदर्द, दृष्टि में बदलाव, या सांस लेने में कठिनाई होने पर तुरंत डॉक्टर से संपर्क करें।

💡 Did You Know? The Indian pharmaceutical market is expected to reach $130 billion by 2030.

💊 cytarabine 1000mg injection Uses & Benefits

[{"condition":"Acute myeloid leukemia (AML)","description":"This medicine is a cornerstone of induction and consolidation chemotherapy for AML, often combined with anthracyclines or other agents.","evidence":"Well-established"},{"condition":"Acute lymphoblastic leukemia (ALL)","description":"Used in multi-agent chemotherapy regimens for both adult and pediatric ALL, especially in central nervous system-directed therapy.","evidence":"Well-established"},{"condition":"Meningeal leukemia and lymphomatous meningitis","description":"Given intrathecally, though this product is for intravenous use, cytarabine is a standard intrathecal agent for central nervous system involvement.","evidence":"Well-established"},{"condition":"Chronic myelogenous leukemia (CML) blast crisis","description":"May be used in blast phase disease, often in combination with other agents.","evidence":"Established"},{"condition":"Non-Hodgkin lymphoma","description":"Included in some salvage or high-dose regimens for certain aggressive lymphomas.","evidence":"Established"},{"condition":"Stem cell transplantation conditioning","description":"Part of high-dose conditioning regimens before allogeneic or autologous transplant in selected patients.","evidence":"Established"}]

Off-label uses: [{"condition":"Acute promyelocytic leukemia (APL) consolidation","description":"Sometimes included in consolidation regimens for APL in specific protocols.","evidence":"Limited"},{"condition":"Optic nerve glioma or other rare CNS tumors","description":"Occasionally used in selected rare tumors under specialist supervision.","evidence":"Limited"}]

Primary treatment for: Acute myeloid leukemia (AML)

Also treats: Acute lymphoblastic leukemia (ALL), Meningeal leukemia, Chronic myelogenous leukemia (CML) blast crisis, Non-Hodgkin lymphoma, Stem cell transplantation conditioning

📋 Drug Information

Generic Name(s)Cytarabine
Brand NameArasid 1000mg Injection
ManufacturerPfizer Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI NEOPLASTICS
Action ClassAntimetabolites
Route of AdministrationIntravenous (IV) infusion or injection. This product is for intravenous use only and must be administered by a qualified healthcare professional
StorageStore this medicine in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze. Protect from light. Keep in the original carton until use. Follow institutional guidelines for handling and disposal of cytotoxic drugs.
Shelf LifeThe shelf life is typically 24 months from the date of manufacture when stored under recommended conditions. Refer to the product label for the exact expiry date.
WHO GuidelineNot established from the available information for this specific product. Cytarabine is included in many international treatment protocols for leukemia, but specific WHO guideline recommendations should be verified from current WHO publications.
ICMR GuidelineNot established from the available information for this specific product. Refer to current ICMR guidelines for cancer treatment in India.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Administer this medicine only in a setting where blood counts and vital signs can be monitored closely.
2
Premedicate with anti-nausea medicines as prescribed to reduce vomiting.
3
Encourage good oral hygiene and use of prescribed mouth rinses to prevent or manage mucositis.
4
Monitor for cytarabine syndrome and treat with corticosteroids if it occurs.
5
Use prophylactic eye drops during high-dose therapy to prevent eye toxicity.
6
Ensure adequate hydration to protect kidney function.
7
Avoid live vaccines and close contact with people who have active infections.
8
Review all concomitant medications for potential interactions before each cycle.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
Leukemia diagnosis
This medicine is commonly prescribed for acute leukemias.
Likely Use
❌
Fever
This medicine is not a fever reducer; fever may be a sign of infection and requires urgent evaluation.
Not Primary
❌
Joint pain
This medicine is not used for joint pain.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is given intravenously, so absorption from the gastrointestinal tract is not applicable. After intravenous administration, cytarabine is rapidly distributed and cleared from the blood.
DistributionCytarabine distributes widely into body fluids and tissues, including cerebrospinal fluid, though cerebrospinal fluid levels are lower than plasma levels after intravenous dosing. It crosses the blood-brain barrier to a limited extent, which is why intrathecal administration is used for meningeal disease.
Protein BindingCytarabine is approximately 13% bound to plasma proteins.
MetabolismCytarabine is primarily metabolized in the liver and other tissues by cytidine deaminase to inactive uracil arabinoside (ara-U). Intracellular activation to cytarabine triphosphate is required for cytotoxic activity.
Half-LifeThe plasma elimination half-life of cytarabine is approximately 1 to 3 hours after intravenous administration. The metabolite ara-U has a longer half-life of about 3 to 6 hours.
ExcretionCytarabine and its metabolites are excreted mainly in the urine, with about 70% to 80% of a dose recovered in urine as ara-U and a smaller amount as unchanged drug.
BioavailabilityNot applicable for intravenous administration; intravenous route provides 100% bioavailability by definition.
Onset of ActionThe cytotoxic effects begin after cellular uptake and activation, which occurs within hours of administration. Clinical effects on blood counts typically appear within 5 to 7 days.
Peak Plasma TimePeak plasma concentrations occur at the end of intravenous infusion or immediately after bolus injection.
Duration of ActionThe cytotoxic effect persists as long as active metabolites remain in cells, but the plasma half-life is short. Bone marrow suppression typically lasts 1 to 2 weeks after a dose.

How It Works

Cytarabine is a pyrimidine nucleoside analogue that must be activated inside cells. It enters cells and is phosphorylated to cytarabine triphosphate, which competes with the natural nucleotide deoxycytidine triphosphate for incorporation into DNA. Once incorporated, it acts as a chain terminator and inhibits DNA polymerase, blocking DNA synthesis and repair. This primarily affects cells that are actively dividing, such as leukemia cells, leading to cell death. Cytarabine also has some inhibitory effect on ribonucleotide reductase, further reducing the building blocks needed for DNA synthesis.

Mechanism Steps

1
Cellular uptake: Cytarabine enters cells through nucleoside transporters.
2
Intracellular activation: It is phosphorylated by deoxycytidine kinase to cytarabine monophosphate, then to diphosphate and triphosphate.
3
DNA incorporation: Cytarabine triphosphate competes with deoxycytidine triphosphate and is incorporated into DNA by DNA polymerase.
4
Chain termination and DNA damage: Incorporation blocks further DNA synthesis and repair, leading to cell cycle arrest and apoptosis.
5
Cell death: Leukemia cells that cannot repair DNA undergo programmed cell death.

💡 How to Take cytarabine 1000mg injection

Strength: This product is a sterile injection containing cytarabine 1000 mg. It is supplied as a single-use vial for intravenous administration.

1This medicine is given by a healthcare professional in a hospital or clinic setting.
2It is administered intravenously, usually as an infusion over a specified period.
3Your doctor will determine the exact dose and schedule based on your condition.
4Blood tests will be done regularly to monitor your blood counts and organ function.
5Report any side effects or new symptoms to your healthcare team promptly.
6Follow all instructions for anti-nausea medicines, eye drops, and hydration.

Dosage Information

Adult DosageThe dose of this medicine is highly individualized and depends on the specific cancer, treatment protocol, and patient factors. For acute myeloid leukemia induction, common regimens include cytarabine 100 mg/m²/day by continuous intravenous infusion for 7 days, often combined with an anthracycline. For high-dose regimens, doses of 1 to 3 g/m² every 12 hours may be used. Dose must be individualized by a qualified clinician based on indication, age, weight, renal and hepatic function, and prior treatments. This information is for educational reference only and is not a prescription.
Pediatric DosagePediatric dosing is not established from available information for this specific product. Cytarabine is used in pediatric leukemia protocols, but dosing must be determined by a pediatric oncologist based on body surface area, indication, and protocol. Consult a pediatric oncologist.
Elderly DosageElderly patients may be more sensitive to the toxic effects of this medicine, especially bone marrow suppression, infections, and neurological toxicity. Doses may need to be reduced or adjusted based on kidney and liver function, performance status, and comorbidities. Close monitoring is essential.
Renal ImpairmentDose adjustments may be necessary in patients with kidney impairment, especially for high-dose regimens. Kidney function should be monitored closely, and doses should be individualized by a qualified clinician.
Hepatic ImpairmentDose adjustments may be necessary in patients with liver impairment. Liver function should be monitored, and doses should be individualized by a qualified clinician.
Maximum Daily DoseThe maximum daily dose varies by protocol and indication. High-dose regimens may use up to 3 g/m² every 12 hours for a limited number of doses. The exact maximum must be determined by the treating oncologist.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

With food
Eat small, frequent meals as tolerated
Helps manage nausea and maintain nutrition.
Grapefruit
Avoid or limit
May affect liver enzymes, though specific interaction is not well established.
Alcohol
Avoid
Increases risk of liver toxicity and worsens nausea.
Spicy or acidic foods
Limit during mucositis
Can worsen mouth sores.

⏰ What to Do If You Miss a Dose

📌 You miss an appointment for your dose
→ Contact your oncology clinic as soon as possible to reschedule.
💡 Do not attempt to self-administer or double the dose.
📌 You are unable to attend due to illness
→ Inform your doctor and follow their advice.
💡 Your treatment schedule may need adjustment.

⚠️ Side Effects of cytarabine 1000mg injection

✅ Common Side Effects

Nausea and vomiting (Common (10-30%))
Take anti-nausea medicines as prescribed. Small frequent meals may help.
Mouth sores (mucositis) (Common (10-30%))
Use a soft toothbrush, rinse with prescribed mouthwash, and avoid spicy or acidic foods.
Fever (Common (10-30%))
Report any fever to your doctor immediately, as it may indicate infection.
Rash (Common (5-10%))
Inform your doctor. Avoid scratching and use gentle skin care.
Fatigue (Common (10-30%))
Rest as needed and pace your activities.
Loss of appetite (Common (10-30%))
Eat small, frequent meals and drink fluids as tolerated.

🚨 Serious Side Effects

Severe bone marrow suppression (neutropenia, thrombocytopenia, anemia) (Common (expected))
Blood counts are monitored regularly. Report fever, bruising, or bleeding immediately.
Serious infections (Common)
Seek immediate medical attention for fever, chills, or signs of infection.
Cytarabine syndrome (fever, myalgia, bone pain, rash, chest discomfort) (Uncommon)
Report to your doctor promptly; corticosteroids may be prescribed.
Liver toxicity (Uncommon)
Liver function tests are monitored. Report yellowing of eyes or skin, dark urine, or abdominal pain.
Kidney toxicity (Uncommon)
Stay hydrated as advised. Report decreased urine output or swelling.
Neurotoxicity (confusion, seizures, peripheral neuropathy) (Rare)
Report confusion, weakness, numbness, or seizures immediately.
Cardiotoxicity (chest pain, arrhythmias) (Rare)
Seek emergency care for chest pain, palpitations, or shortness of breath.

⚠️ Rare Side Effects

Pancreatitis
Report severe upper abdominal pain radiating to the back.
Severe skin reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis)
Seek emergency care for blistering rash, peeling skin, or sores in mouth or eyes.
Acute respiratory distress syndrome (ARDS)
Seek emergency care for severe shortness of breath or low oxygen.
Optic neuropathy or conjunctivitis
Use prescribed eye drops and report vision changes.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Live vaccines Major
Other myelosuppressive agents Major
Digoxin Moderate
Aminoglycosides Moderate
Flucytosine Moderate
Methotrexate Moderate
Warfarin Moderate
Paracetamol Minor
Ondansetron Minor
Alcohol Moderate

🚨 Major Interactions

  • Live vaccines
  • Other myelosuppressive chemotherapy or radiation
  • Digoxin
  • Gentamicin and other aminoglycosides

⚡ Moderate Interactions

  • Flucytosine
  • Methotrexate
  • Warfarin

🍷 Alcohol Interaction

Alcohol should be avoided while receiving this medicine because it can increase the risk of liver toxicity, worsen nausea and vomiting, and add to fatigue. It may also increase the risk of bleeding if platelet counts are low.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Known hypersensitivity to cytarabine or any component of the formulation","Active serious infection unless the treating clinician decides benefit outweighs risk","Severe bone marrow suppression unless part of the intended treatment","Pregnancy, unless the potential benefit justifies the potential risk","Breastfeeding, unless breastfeeding is discontinued"]

⚠️ Warnings & Precautions

["This medicine should be administered only by healthcare professionals experienced in cancer chemotherapy.","Bone marrow suppression is expected and can be severe; blood counts must be monitored closely.","Serious infections can occur; patients should report fever promptly.","Cytarabine syndrome can occur and may require corticosteroid treatment.","High-dose therapy can cause severe neurological toxicity, including seizures and coma.","Eye toxicity can occur with high-dose therapy; prophylactic eye drops are often prescribed.","Liver and kidney function should be monitored regularly.","Live vaccines should be avoided during treatment.","Patients should use effective contraception during and after treatment.","This medicine can cause fetal harm; pregnant women should be informed of the potential risks."]

🤱 Lactation Safety

It is not known whether cytarabine is excreted in human milk. Because of the potential for serious adverse reactions in a nursing infant, breastfeeding should be discontinued during treatment and for a period after treatment as advised by the doctor.

💊 Overdose Management

There is no specific antidote for cytarabine overdose. Management should be supportive and symptomatic, with close monitoring of blood counts, liver and kidney function, and neurological status. In case of suspected overdose, contact a poison control center or emergency services immediately. Patients may require hospitalization for monitoring and management of severe bone marrow suppression, infections, or other complications.

⏰ Missed Dose

This medicine is given by healthcare professionals in a controlled setting, so missed doses are managed by the treating team. If you miss an appointment for your dose, contact your oncology clinic as soon as possible to reschedule. Do not attempt to self-administer or double the dose.

Additional Safety Advice

General Safety

This medicine must be given only by a qualified healthcare professional in a setting where blood counts, liver function, kidney function, and vital signs can be monitored closely. Do not attempt to administer it at home. Inform your doctor about all medicines, supplements, and herbal products you take, because some can increase the risk of bleeding, infection, or organ toxicity. Avoid close contact with people who have active infections, and practice good hand hygiene. Use a soft toothbrush and an electric razor to reduce bleeding risk when platelet counts are low. Drink fluids as advised to help protect the kidneys, and follow all instructions for anti-nausea medicines and eye drops. Do not receive live vaccines during treatment without asking your oncologist. Use effective contraception during treatment and for a period after treatment as advised by your doctor, because this medicine can harm a developing baby. Report fever of 100.4°F (38°C) or higher, chills, sore throat, easy bruising, blood in urine or stool, severe headache, vision changes, or difficulty breathing immediately.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients are at higher risk of severe bone marrow suppression, infections, and neurological toxicity. Doses may need to be reduced, and close monitoring is essential. Discuss the risks and benefits with your doctor, and consider geriatric assessment to guide treatment decisions.

🤰 Pregnancy Planning (TTC)

This medicine can cause fetal harm. Women of childbearing potential should use effective contraception during treatment and for a period after treatment as advised by their doctor. Men should also use effective contraception. If you are planning pregnancy, discuss with your oncologist before starting treatment, as fertility preservation options may be available.

🏥 Post-Surgery Considerations

If you have recently had surgery, inform your surgeon and oncologist. This medicine can impair wound healing and increase infection risk. Your treatment schedule may need to be adjusted around surgery. Close monitoring for bleeding and infection is important.

🦷 Dental Procedures

Inform your dentist that you are receiving this medicine. Dental procedures may need to be postponed if your blood counts are low, due to increased risk of bleeding and infection. Your dentist and oncologist should coordinate your care. Good oral hygiene is important to prevent complications.

💚 Lifestyle Tips for Better Results

🏃
Maintain good hand hygiene to reduce infection risk.
🥗
Avoid crowds and people with active infections.
😴
Eat a balanced diet with adequate protein and calories.
💧
Stay well hydrated unless advised otherwise.
🧘
Get plenty of rest and pace your activities.
🌞
Use a soft toothbrush and electric razor to reduce bleeding risk.
🚭
Follow your doctor's advice on eye drops and mouth care.
🥑
Attend all scheduled blood tests and follow-up appointments.

🏋️ Exercise Considerations

Discuss exercise with your doctor before starting any routine. During treatment, your blood counts may be low, so strenuous exercise or activities with a risk of injury should be avoided. Light walking or gentle stretching may be appropriate if you feel well, but always prioritize rest when fatigued.

🥗 Diet Recommendations

Eat small, frequent meals to manage nausea.
Include protein-rich foods to support recovery.
Avoid raw or undercooked foods to reduce infection risk.
Drink plenty of fluids to stay hydrated.
Limit spicy and acidic foods if you have mouth sores.
Avoid alcohol during treatment.

💼 Impact on Daily Work & Life

This medicine can cause significant fatigue, nausea, and increased infection risk, which may affect your ability to work. Most patients need to take time off during treatment cycles. Driving and operating machinery should be avoided if you feel dizzy, fatigued, or confused. Discuss your work situation with your doctor and employer to plan for necessary leave.

🛑 When to Stop This Medicine

Do not stop this medicine without consulting your oncologist. Treatment schedules are carefully planned, and stopping early can reduce effectiveness and increase the risk of relapse. If you experience severe side effects, your doctor may adjust the dose or delay treatment. Always follow your healthcare team's guidance.

📅 Long-Term Use Effects

Long-term effects of this medicine may include persistent bone marrow suppression, increased risk of secondary cancers, and organ toxicity. Some patients may experience lasting fatigue or neurological effects, especially after high-dose therapy. Regular follow-up with your oncologist is important to monitor for late effects and to manage any ongoing symptoms. Fertility may be affected; discuss fertility preservation options before treatment if applicable.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Other chemotherapy regimens

Depending on the type and stage of leukemia, other chemotherapy combinations may be used.

Evidence: Well-established
Targeted therapy

For certain genetic mutations, targeted drugs may be used alone or in combination.

Evidence: Established for specific subtypes
Stem cell transplantation

May be curative for some patients, often after cytarabine-based conditioning.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

Live vaccines should be avoided during treatment with this medicine because of the risk of vaccine-related infection. Inactivated vaccines may be given, but their effectiveness may be reduced. Discuss vaccination with your oncologist, and ensure household members are up to date on their vaccines to reduce your risk of exposure.

📦 Storage Guide

✅ DO

Store in a refrigerator at 2°C to 8°C (36°F to 46°F)

❌ DON'T

Do not freeze

✅ DO

Keep in the original carton to protect from light

❌ DON'T

Do not transfer to unmarked containers

✅ DO

Follow institutional guidelines for cytotoxic drug handling

❌ DON'T

Do not store at room temperature for prolonged periods

✈️ Traveling with This Medicine

This medicine is administered in a hospital or clinic, so travel planning should be coordinated with your oncology team. If you need to travel during treatment, carry a copy of your prescription and medical records. This medicine is stored in a refrigerator, so it must be transported under proper cold-chain conditions by healthcare professionals. Do not carry it in personal luggage. Plan travel around your treatment schedule and ensure you have access to a medical facility in case of complications. Discuss any travel plans with your doctor in advance.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 52-year-old man diagnosed with acute myeloid leukemia
He received this medicine as part of his induction chemotherapy in the hospital. He experienced nausea and mouth sores, which were managed with anti-nausea medicines and mouth rinses. His blood counts dropped as expected, and he needed antibiotics for a fever. With close monitoring, he completed his treatment and achieved remission.
💡 Lesson: Close monitoring and prompt management of side effects are essential during cytarabine therapy.
👤 A 34-year-old woman with acute lymphoblastic leukemia
She received this medicine in combination with other chemotherapy drugs. She was advised to use eye drops to prevent eye irritation and to drink plenty of fluids. She reported fatigue and loss of appetite but was able to continue treatment with support. She emphasized the importance of following the treatment schedule and reporting symptoms early.
💡 Lesson: Following preventive measures and communicating with the healthcare team helps patients tolerate treatment better.

💬 Questions Patients Often Ask

Q: How long does it take for this medicine to work?

A: The effects on leukemia cells begin within hours, but clinical response is usually assessed after completing a treatment cycle, which may take several weeks. Your doctor will monitor your blood and bone marrow to evaluate response.

Q: Can I receive this medicine at home?

A: No, this medicine must be given in a hospital or clinic by a healthcare professional because it requires close monitoring and management of serious side effects.

Q: What should I do if I develop a fever?

A: Contact your doctor immediately. Fever may be a sign of a serious infection, especially when your white blood cell count is low.

Q: Is it safe to become pregnant during treatment?

A: No, this medicine can harm a developing baby. Use effective contraception during treatment and for a period after treatment as advised by your doctor.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can I take this medicine if I have an infection?
  • Will this medicine affect my fertility?
  • Can I drive after receiving this medicine?
  • Does this medicine interact with my other medications?
  • What should I do if I miss a dose?
  • Can I drink alcohol during treatment?
  • How long will I need to take this medicine?
  • What are the long-term effects of this medicine?

🔄 Substitutes for cytarabine 1000mg injection

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: Cytarabine injection can be self-administered at home.
    Fact: This medicine must be given by a healthcare professional in a controlled setting due to its serious side effects and need for monitoring.
  • Myth: Cytarabine is safe for everyone with cancer.
    Fact: It is used for specific types of leukemia and lymphoma and is not appropriate for all cancers. It has significant risks and contraindications.
  • Myth: You can stop cytarabine treatment if you feel better.
    Fact: Treatment schedules are carefully planned. Stopping early can reduce effectiveness and increase the risk of relapse. Always consult your oncologist.

🔄 Alternative Options

Generic Alternatives

  • Cytarabine injection

Brand Alternatives

  • Arasid 1000mg injection

📊 Comparison with Similar Medicines

[{"medicine":"Cytarabine","class":"Antimetabolite","primary_use":"AML, ALL, meningeal leukemia","route":"Intravenous, intrathecal"},{"medicine":"Daunorubicin","class":"Anthracycline","primary_use":"AML, ALL","route":"Intravenous"},{"medicine":"Fludarabine","class":"Purine analogue","primary_use":"CLL, AML, conditioning","route":"Intravenous, oral"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory